Market Overview:
The global specialty pharmaceutical market is expected to grow at a CAGR of 7.8% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising geriatric population, and technological advancements in the field of specialty pharmaceuticals. The global specialty pharmaceutical market is segmented on the basis of type into antibody, hormone, growth factors, and other types. The antibody segment is expected to grow at a CAGR of 8.5% from 2018 to 2030 due to the increasing demand for monoclonal antibodies for the treatment of various diseases such as cancer and autoimmune disorders. The hormone segment is projected to grow at a CAGR of 7.7% from 2018-2030 due its use in treating various chronic diseases such as diabetes and cardiovascular disorders. On the basis application,the global specialty pharmaceuticals market is divided into tumor therapy, diabetes therapy,,cardiovascular therapy,,hemophilia therapy,,and other therapies segments .The tumor therapy segment accounted for majority share (36%)of th eglobal speciality pharmaceutics mar ketin 2017 an dis expec tedtog rowatac agr o f8 .
Product Definition:
A Specialty Pharmaceutical is a pharmaceutical product that is used to treat a rare or complex medical condition. These products are often expensive and require special handling and administration. The importance of specialty pharmaceuticals lies in their ability to address the needs of patients with rare or complex conditions.
Antibody:
Antibody is a protein made by the body to fight bacteria, viruses, and other harmful substances. The immune system makes antibodies in response to foreign objects (such as food or germs) that enter the body and attacks them. Antibodies are proteins that bind themselves to specific substances so they can be identified by scientists. They are used for diagnosing diseases as well as therapeutic purposes (to treat disease).
Hormone:
Hormone is a chemical messenger that facilitates communication between cells in the human body. Hormones are released by the cells of the endocrine system in response to certain external factors. The main functions of hormones are to allow information transfer between cells, regulate cell growth & differentiation, and control metabolic processes. There are two types of hormones: peptide and non-peptide.
Application Insights:
The other application segment includes infectious diseases, nephrological disease, respiratory disease and others. Other applications include tumor treatment, diabetes treatment, cardiovascular treatment and hemophilia treatment among others. The growing incidences of cancer across the globe are expected to be a major driving factor for this market over the forecast period. According to WHO in 2018, it is estimated that around 1 in 6 people globally are diagnosed with cancer during their lifetime while about 2 in 5 deaths occur due to cancer worldwide every year.
Specialty pharmaceutical products for tumor management include anti-cancer drugs & biologics which have high success rates compared to traditional therapies owing to its ability of targeted delivery system.
Regional Analysis:
North America dominated the global market in 2017. The growth of this region can be attributed to factors such as favorable reimbursement policies, presence of key manufacturers and well-established healthcare infrastructure. Moreover, increasing prevalence of cancer and other chronic diseases is also expected to drive the demand for specialty pharmaceuticals in this region over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income coupled with improving healthcare facilities in emerging countries such as China and India. These countries are recognized worldwide for their excellent research capabilities related to biotechnology & pharmaceutical industry; hence, many major companies have established their manufacturing units here due to low costs associated with production process as compared to developed regions (e.g., North America). This factor will further boost regional market development during the forecast period from 2018 To 2030 (see figure below).
Growth Factors:
- Increasing prevalence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. As a result, there is an increased demand for specialty pharmaceuticals that can help in the treatment and management of these conditions.
- Rising awareness about specialty drugs: There has been a significant increase in awareness about the benefits offered by specialty drugs in recent years. This has led to an increase in demand for these medications from both patients and healthcare professionals alike.
- Advances in drug delivery technologies: Drug delivery technologies are evolving rapidly, offering new and innovative ways to administer specialty pharmaceuticals to patients effectively and safely. This is helping to drive growth in this market segment significantly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Specialty Pharmaceutical Market Research Report
By Type
Antibody, Hormone, Growth Factors, Other
By Application
Tumor, Diabetes, Cardiovascular, Hemophilia, Other
By Companies
Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson, Sanofi-Aventis, Merck, Eli Lilly, Novartis, Pfizer, Changchun High Tech, CP Guojian Pharmacy, Biotech Pharma, Gelgen Biopharma, Innovent
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
194
Number of Tables & Figures
136
Customization Available
Yes, the report can be customized as per your need.
Global Specialty Pharmaceutical Market Report Segments:
The global Specialty Pharmaceutical market is segmented on the basis of:
Types
Antibody, Hormone, Growth Factors, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Tumor, Diabetes, Cardiovascular, Hemophilia, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Pfizer
- Roche
- Amgen
- AbbVie
- Novo Nordisk
- Johnson & Johnson
- Sanofi-Aventis
- Merck
- Eli Lilly
- Novartis
- Pfizer
- Changchun High Tech
- CP Guojian Pharmacy
- Biotech Pharma
- Gelgen Biopharma
- Innovent
Highlights of The Specialty Pharmaceutical Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Antibody
- Hormone
- Growth Factors
- Other
- By Application:
- Tumor
- Diabetes
- Cardiovascular
- Hemophilia
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Specialty Pharmaceutical Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Specialty Pharmaceuticals is a global specialty pharmaceutical company. The company develops, manufactures and markets products for the healthcare market. Specialty Pharmaceuticals' products include injectables, tablets and capsules for the treatment of cancer, cardiovascular diseases and other medical conditions.
Some of the major companies in the specialty pharmaceutical market are Pfizer, Roche, Amgen, AbbVie, Novo Nordisk, Johnson & Johnson, Sanofi-Aventis, Merck, Eli Lilly, Novartis, Pfizer, Changchun High Tech, CP Guojian Pharmacy, Biotech Pharma, Gelgen Biopharma, Innovent.
The specialty pharmaceutical market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Specialty Pharmaceutical Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Specialty Pharmaceutical Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Specialty Pharmaceutical Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Specialty Pharmaceutical Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Specialty Pharmaceutical Market Size & Forecast, 2020-2028
4.5.1 Specialty Pharmaceutical Market Size and Y-o-Y Growth
4.5.2 Specialty Pharmaceutical Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Antibody
5.2.2 Hormone
5.2.3 Growth Factors
5.2.4 Other
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Tumor
6.2.2 Diabetes
6.2.3 Cardiovascular
6.2.4 Hemophilia
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Specialty Pharmaceutical Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Specialty Pharmaceutical Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Antibody
9.6.2 Hormone
9.6.3 Growth Factors
9.6.4 Other
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Tumor
9.10.2 Diabetes
9.10.3 Cardiovascular
9.10.4 Hemophilia
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Antibody
10.6.2 Hormone
10.6.3 Growth Factors
10.6.4 Other
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Tumor
10.10.2 Diabetes
10.10.3 Cardiovascular
10.10.4 Hemophilia
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Antibody
11.6.2 Hormone
11.6.3 Growth Factors
11.6.4 Other
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Tumor
11.10.2 Diabetes
11.10.3 Cardiovascular
11.10.4 Hemophilia
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Antibody
12.6.2 Hormone
12.6.3 Growth Factors
12.6.4 Other
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Tumor
12.10.2 Diabetes
12.10.3 Cardiovascular
12.10.4 Hemophilia
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Antibody
13.6.2 Hormone
13.6.3 Growth Factors
13.6.4 Other
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Tumor
13.10.2 Diabetes
13.10.3 Cardiovascular
13.10.4 Hemophilia
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Specialty Pharmaceutical Market: Competitive Dashboard
14.2 Global Specialty Pharmaceutical Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Pfizer
14.3.2 Roche
14.3.3 Amgen
14.3.4 AbbVie
14.3.5 Novo Nordisk
14.3.6 Johnson & Johnson
14.3.7 Sanofi-Aventis
14.3.8 Merck
14.3.9 Eli Lilly
14.3.10 Novartis
14.3.11 Pfizer
14.3.12 Changchun High Tech
14.3.13 CP Guojian Pharmacy
14.3.14 Biotech Pharma
14.3.15 Gelgen Biopharma
14.3.16 Innovent
